TickerFacts.

Pasithea Therapeutics Corp. (KTTA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$113.2K
Year ended 2022-12-31
2021-12-31: $17.3K2022-12-31: $113.2K$113.2K
2021-12-31 Cost of Revenue (USD) 2022-12-31
Period endedCost of RevenueChange YoYSource filing
2022-12-31$113.2K+555.3%2023-03-30, From 2022-01-01
2021-12-31$17.3Kn/a2023-03-30, From 2021-01-01